1. Home
  2. ZYXI vs AGD Comparison

ZYXI vs AGD Comparison

Compare ZYXI & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • AGD
  • Stock Information
  • Founded
  • ZYXI 1996
  • AGD 2006
  • Country
  • ZYXI United States
  • AGD United Kingdom
  • Employees
  • ZYXI N/A
  • AGD N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AGD Trusts Except Educational Religious and Charitable
  • Sector
  • ZYXI Health Care
  • AGD Finance
  • Exchange
  • ZYXI Nasdaq
  • AGD Nasdaq
  • Market Cap
  • ZYXI 261.5M
  • AGD 250.4M
  • IPO Year
  • ZYXI N/A
  • AGD N/A
  • Fundamental
  • Price
  • ZYXI $7.19
  • AGD $10.27
  • Analyst Decision
  • ZYXI Strong Buy
  • AGD
  • Analyst Count
  • ZYXI 2
  • AGD 0
  • Target Price
  • ZYXI $14.00
  • AGD N/A
  • AVG Volume (30 Days)
  • ZYXI 76.5K
  • AGD 61.2K
  • Earning Date
  • ZYXI 03-07-2025
  • AGD 01-01-0001
  • Dividend Yield
  • ZYXI N/A
  • AGD 8.13%
  • EPS Growth
  • ZYXI N/A
  • AGD N/A
  • EPS
  • ZYXI 0.15
  • AGD N/A
  • Revenue
  • ZYXI $193,665,000.00
  • AGD N/A
  • Revenue This Year
  • ZYXI $10.70
  • AGD N/A
  • Revenue Next Year
  • ZYXI $19.78
  • AGD N/A
  • P/E Ratio
  • ZYXI $48.68
  • AGD N/A
  • Revenue Growth
  • ZYXI 4.21
  • AGD N/A
  • 52 Week Low
  • ZYXI $7.12
  • AGD $8.20
  • 52 Week High
  • ZYXI $13.77
  • AGD $9.78
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 34.08
  • AGD 51.62
  • Support Level
  • ZYXI $7.27
  • AGD $10.18
  • Resistance Level
  • ZYXI $7.70
  • AGD $10.51
  • Average True Range (ATR)
  • ZYXI 0.28
  • AGD 0.12
  • MACD
  • ZYXI -0.04
  • AGD 0.01
  • Stochastic Oscillator
  • ZYXI 6.93
  • AGD 52.00

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest

Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.

Share on Social Networks: